These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 8876138)
1. Applications of pox virus vectors to vaccination: an update. Paoletti E Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11349-53. PubMed ID: 8876138 [TBL] [Abstract][Full Text] [Related]
2. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. Welter J; Taylor J; Tartaglia J; Paoletti E; Stephensen CB J Virol; 2000 Jul; 74(14):6358-67. PubMed ID: 10864646 [TBL] [Abstract][Full Text] [Related]
3. Efficacy studies on a canarypox-rabies recombinant virus. Taylor J; Trimarchi C; Weinberg R; Languet B; Guillemin F; Desmettre P; Paoletti E Vaccine; 1991 Mar; 9(3):190-3. PubMed ID: 2042391 [TBL] [Abstract][Full Text] [Related]
4. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840 [TBL] [Abstract][Full Text] [Related]
5. Development of a recombinant vaccinia-rabies vaccine for oral vaccination of foxes against rabies. Pastoret PP; Brochier B Dev Biol Stand; 1992; 79():105-11. PubMed ID: 1286744 [TBL] [Abstract][Full Text] [Related]
7. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244 [TBL] [Abstract][Full Text] [Related]
8. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens. da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801 [TBL] [Abstract][Full Text] [Related]
9. [Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat]. Blancou J; Artois M; Brochier B; Thomas I; Pastoret PP; Desmettre P; Languet B; Kiény MP Ann Rech Vet; 1989; 20(2):195-204. PubMed ID: 2751231 [TBL] [Abstract][Full Text] [Related]
10. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Taylor J; Weinberg R; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E Virology; 1992 Mar; 187(1):321-8. PubMed ID: 1736535 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC. Tartaglia J; Cox WI; Pincus S; Paoletti E Dev Biol Stand; 1994; 82():125-9. PubMed ID: 7958466 [TBL] [Abstract][Full Text] [Related]
12. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses. Kim SH; Samal SK Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574 [TBL] [Abstract][Full Text] [Related]
13. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. Brochier B; Aubert MF; Pastoret PP; Masson E; Schon J; Lombard M; Chappuis G; Languet B; Desmettre P Rev Sci Tech; 1996 Sep; 15(3):947-70. PubMed ID: 9025144 [TBL] [Abstract][Full Text] [Related]
14. Immunisation with canarypox virus expressing rabies glycoprotein. Cadoz M; Strady A; Meignier B; Taylor J; Tartaglia J; Paoletti E; Plotkin S Lancet; 1992 Jun; 339(8807):1429-32. PubMed ID: 1351126 [TBL] [Abstract][Full Text] [Related]
15. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Lodmell DL; Esposito JJ; Ewalt LC Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356 [TBL] [Abstract][Full Text] [Related]
16. Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus. Jones L; Tenorio E; Gorham J; Yilma T Am J Vet Res; 1997 Jun; 58(6):590-3. PubMed ID: 9185963 [TBL] [Abstract][Full Text] [Related]
17. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451 [TBL] [Abstract][Full Text] [Related]
18. Oral rabies vaccine contact by raccoons and nontarget species in a field trial in Florida. Olson CA; Werner PA J Wildl Dis; 1999 Oct; 35(4):687-95. PubMed ID: 10574527 [TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line. Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831 [TBL] [Abstract][Full Text] [Related]
20. Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge. Wang FX; Zhang SQ; Zhu HW; Yang Y; Sun N; Tan B; Li ZG; Cheng SP; Fu ZF; Wen YJ Vet Microbiol; 2014 Dec; 174(3-4):362-371. PubMed ID: 25465178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]